|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from/(used in) operating activities: | |||||
| Profit for the year | |||||
| Adjustments for: | |||||
| Tax expense, net | |||||
| Fair value changes and profit on sale of financial instruments measured at FVTPL, net | |||||
| Depreciation and amortization | |||||
| Impairment of non-current assets, net | |||||
| Allowance for credit losses (on trade receivables and other advances) | |||||
| (Profit)/ Loss on sale/disposal of assets, net | |||||
| Share of profit of equity accounted investees | |||||
| Unrealized exchange (gain)/loss, net | |||||
| Interest (income)/expense, net | |||||
| Inventories write-down | |||||
| Equity settled share-based payment expense | |||||
| Dividend income | |||||
| Changes in operating assets and liabilities: | |||||
| Trade and other receivables | |||||
| Inventories | |||||
| Trade and other payables | |||||
| Other assets and other liabilities, net | |||||
| Cash generated from operations | |||||
| Income tax paid, net | |||||
| Net cash from operating activities | |||||
| Cash flows from/(used in) investing activities: | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchase of other intangible assets | |||||
| Proceeds from sale of other intangible assets | |||||
| Payment for acquisition of businesses | |||||
| Investment in associates | |||||
| Purchase of other investments (including bank deposits) | |||||
| Proceeds from sale of other investments (including bank deposits) | |||||
| Dividends received from equity accounted investees | |||||
| Interest and dividend received | |||||
| Net cash used in investing activities | |||||
| Cash flows from/(used in) financing activities: | |||||
| Proceeds from issuance of equity shares (including treasury shares) | |||||
| Purchase of treasury shares | |||||
| Proceeds from sale of treasury shares | |||||
| Proceeds from/(repayment of) short-term borrowings, net | |||||
| Proceeds from long-term borrowings (Refer to Note 16 for details) | |||||
| Repayment of long-term borrowings (Refer to Note 16 for details) | |||||
| Proceeds from issuance of equity shares in subsidiary comprising NCI (Refer to Note 35.A for details) | |||||
| Payment of principal portion of lease liabilities (Refer to Note 16 for details) | |||||
| Dividend paid | |||||
| Interest paid | |||||
| Net cash from/(used) in financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year (Refer to Note 6 for details) | |||||
Loading...
